Blueblood Ventures Governance and Expansion Update

• Internal Auditor: M/s. Mahesh Sharma & Associates (FY 2026-31)
• New Additional Director: Mr. Chandrashekhar Singh (Non-Executive Independent)

Reader Takeaway: Improved governance structure follows a five-year audit appointment, balanced by scrutiny on related-party real estate lease.

What just happened

Blueblood Ventures has announced a series of structural changes following its latest Board meeting. The company has appointed M/s. Mahesh Sharma & Associates as internal auditors for a five-year term running from FY 2026-27 to 2030-31, for an annual fee of Rs 25,000. Additionally, the Board appointed Mr. Chandrashekhar Singh as a Non-Executive Independent Director, effective October 9, 2026, pending shareholder approval at the upcoming Annual General Meeting.

Branch and Debt Updates

The company is expanding its footprint by opening a branch office in Kolkata. The premises, located at the Standard Chartered Bank Building on N.S. Road, will be leased for a monthly rent of Rs 20,000 starting October 1, 2026. This lease is classified as a related-party transaction, as the property is owned by Mr. Suresh Bohra. The company has stated its commitment to adhering to all Companies Act and SEBI regulations governing such transactions. Simultaneously, the Board approved a debt assignment involving Mr. Anuranjan Jha, Mr. Pradeep Kumar, and Mr. Amit Kumar Kushwaha, alongside plans to evaluate a potential share transaction with SJM Investments (Delhi) Private Limited.

Why this matters

For investors, these moves highlight a shift toward formalizing long-term internal controls through a five-year audit contract and expanding the company's geographical presence. The appointment of an independent director is designed to strengthen corporate oversight. However, market participants should remain attentive to the specifics of the related-party rental agreement and the final outcomes of the debt and share transactions involving SJM Investments.

What to track next

The primary focus for shareholders will be the ratification of the Independent Director's appointment at the AGM and the disclosure of the finalized terms regarding the SJM Investments transaction.